APOBEC3B and cancer: Importantly, two independent meta-analyses-based studies identified a link between deleterious somatic mutations with cytosine mutation bias in several cancer types and APOBEC expression/enzymatic activities, with one member of the APOBEC3 subfamily, APOBEC3B, being responsible for the majority of cytosine mutations [13, 36].